TET2 and breast carcinoma: These findings are consistent with recent findings that TET2 is highly expressed in HCC tissues, and TET2 overexpression is positively correlated with a shorter survival time, although TET1 upregulation plays an oncogenic role in other cancers, like leukemia [14] and breast cancer [15].